nach oben

Journal of Neurology

Erschienen in:

08.05.2023 | Review

Ordering genetic testing by neurologists: points to consider

verfasst von: Avi Fellner, Yael Goldberg, Lina Basel-Salmon

Erschienen in: Journal of Neurology | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

A significant challenge limiting the comprehensive utilization of genomic medicine is the lack of timely access to genetics specialists. Although neurologists see patients for whom genetic testing should be considered, the knowledge regarding the choice of the optimal genetic test for each case and the management of the test results are out of the scope of their everyday practice. In this review, we provide a step-by-step guide for non-geneticist physicians through the decision-making process when ordering diagnostic genetic testing for monogenic neurological diseases and when dealing with their results.

Shields AE, Burke W, Levy DE (2008) Differential use of available genetic tests among primary care physicians in the United States: results of a national survey. Genet Med 10(6):404–414. https://doi.org/10.1097/GIM.0b013e3181770184CrossRefPubMedPubMedCentral

Mancuso M, Houlden H, Molnar MJ et al (2022) How to approach a neurogenetics diagnosis in different European countries: the European Academy of Neurology Neurogenetics Panel survey. Eur J Neurol 29(7):1885–1891. https://doi.org/10.1111/ene.15320CrossRefPubMedPubMedCentral

Bradley L, Lynch SA (2021) Dying to see you? Deaths on a clinical genetics waiting list in the Republic of Ireland; what are the consequences? J Community Genet 12(1):121–127. https://doi.org/10.1007/s12687-020-00491-3CrossRefPubMed

Shaw T, Metras J, Ting ZAL, Courtney E, Li ST, Ngeow J (2018) Impact of appointment waiting time on attendance rates at a clinical cancer genetics service. J Genet Couns 27(6):1473–1481. https://doi.org/10.1007/s10897-018-0259-zCrossRefPubMed

Maiese DR, Keehn A, Lyon M, Flannery D, Watson M, Working groups of the national coordinating center for seven regional genetics service collaboratives (2019) Current conditions in medical genetics practice. Genet Med 21(8):1874–1877. https://doi.org/10.1038/s41436-018-0417-6CrossRefPubMedPubMedCentral

Kotzer KE, Riley JD, Conta JH, Anderson CM, Schahl KA, Goodenberger ML (2014) Genetic testing utilization and the role of the laboratory genetic counselor. Clin Chim Acta 427:193–195. https://doi.org/10.1016/j.cca.2013.09.033CrossRefPubMed

Miller CE, Krautscheid P, Baldwin EE et al (2014) Genetic counselor review of genetic test orders in a reference laboratory reduces unnecessary testing. Am J Med Genet A 164A(5):1094–1101. https://doi.org/10.1002/ajmg.a.36453CrossRefPubMed

Sandhaus LM, Singer ME, Dawson NV, Wiesner GL (2001) Reporting BRCA test results to primary care physicians. Genet Med 3(5):327–334. https://doi.org/10.1097/00125817-200109000-00001CrossRefPubMed

McGovern MM, Benach M, Zinberg R (2003) Interaction of genetic counselors with molecular genetic testing laboratories: implications for non-geneticist health care providers. Am J Med Genet 119A(3):297–301. https://doi.org/10.1002/ajmg.a.20196CrossRefPubMed

10.

Lalonde E, Rentas S, Lin F, Dulik MC, Skraban CM, Spinner NB (2020) Genomic diagnosis for pediatric disorders: revolution and evolution. Front Pediatr 8:373. https://doi.org/10.3389/fped.2020.00373CrossRefPubMedPubMedCentral

11.

Feldman EL, Goutman SA, Petri S et al (2022) Amyotrophic lateral sclerosis. Lancet 400(10360):1363–1380. https://doi.org/10.1016/S0140-6736(22)01272-7CrossRefPubMed

12.

Guo MH, Bardakjian TM, Brzozowski MR et al (2021) Temporal trends and yield of clinical diagnostic genetic testing in adult neurology. Am J Med Genet A 185(10):2922–2928. https://doi.org/10.1002/ajmg.a.62372CrossRefPubMed

13.

Thomas Q, Vitobello A, Tran Mau-Them F et al (2022) High efficiency and clinical relevance of exome sequencing in the daily practice of neurogenetics. J Med Genet 59(5):445–452. https://doi.org/10.1136/jmedgenet-2020-107369CrossRefPubMed

14.

Wright CF, FitzPatrick DR, Firth HV (2018) Paediatric genomics: diagnosing rare disease in children. Nat Rev Genet 19(5):253–268. https://doi.org/10.1038/nrg.2017.116CrossRefPubMed

15.

Xue Y, Ankala A, Wilcox WR, Hegde MR (2015) Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing. Genet Med 17(6):444–451. https://doi.org/10.1038/gim.2014.122CrossRefPubMed

16.

Stevanovski I, Chintalaphani SR, Gammarachchi H et al (2022) Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing. Sci Adv 8(9):eabm5386. https://doi.org/10.1126/sciadv.abm5386CrossRefPubMedPubMedCentral

17.

Dillon OJ, Lunke S, Stark Z et al (2018) Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders. Eur J Hum Genet 26(5):644–651. https://doi.org/10.1038/s41431-018-0099-1CrossRefPubMedPubMedCentral

18.

Truty R, Rojahn S, Quyang K et al (2023) Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals. Am J Hum Genet 110(4):551–564. https://doi.org/10.1016/j.ajhg.2023.02.013CrossRefPubMed

19.

Saudi Mendeliome Group (2015) Comprehensive gene panels provide advantages over clinical exome sequencing for Mendelian diseases. Genome Biol 16(1):134. https://doi.org/10.1186/s13059-015-0693-2CrossRefPubMedCentral

20.

Sawyer SL, Hartley T, Dyment DA et al (2016) Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care. Clin Genet 89(3):275–284. https://doi.org/10.1111/cge.12654CrossRefPubMed

21.

Wang X, Shen X, Fang F et al (2019) Phenotype-driven virtual panel is an effective method to analyze WES data of neurological disease. Front Pharmacol 9:1529. https://doi.org/10.3389/fphar.2018.01529CrossRefPubMedPubMedCentral

22.

Lionel AC, Costain G, Monfared N et al (2018) Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. Genet Med 20(4):435–443. https://doi.org/10.1038/gim.2017.119CrossRefPubMed

23.

Wenger AM, Guturu H, Bernstein JA, Bejerano G (2017) Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers. Genet Med 19(2):209–214. https://doi.org/10.1038/gim.2016.88CrossRefPubMed

24.

Basel-Salmon L, Orenstein N, Markus-Bustani K et al (2019) Improved diagnostics by exome sequencing following raw data reevaluation by clinical geneticists involved in the medical care of individuals tested. Genet Med 21(6):1443–1451. https://doi.org/10.1038/s41436-018-0343-7CrossRefPubMed

25.

Basel-Salmon L, Ruhrman-Shahar N, Orenstein N et al (2021) When phenotype does not match genotype: importance of “real-time” refining of phenotypic information for exome data interpretation. Genet Med 23(1):215–221. https://doi.org/10.1038/s41436-020-00938-5CrossRefPubMed

26.

Meng L, Attali R, Talmy T et al (2023) Evaluation of an automated genome interpretation model for rare disease routinely used in a clinical genetic laboratory. Genet Med 25(6):100830. https://doi.org/10.1016/j.gim.2023.100830CrossRefPubMed

27.

Tan TY, Lunke S, Chong B et al (2019) A head-to-head evaluation of the diagnostic efficacy and costs of trio versus singleton exome sequencing analysis. Eur J Hum Genet 27(12):1791–1799. https://doi.org/10.1038/s41431-019-0471-9CrossRefPubMedPubMedCentral

28.

Retterer K, Juusola J, Cho MT et al (2016) Clinical application of whole-exome sequencing across clinical indications. Genet Med 18(7):696–704. https://doi.org/10.1038/gim.2015.148CrossRefPubMed

29.

Kalia SS, Adelman K, Bale SJ et al (2017) Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 19(2):249–255. https://doi.org/10.1038/gim.2016.190CrossRefPubMed

30.

Miller DT, Lee K, Abul-Husn NS et al (2022) ACMG SF v3.1 list for reporting for secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 24(7):1407–1414. https://doi.org/10.1016/j.gim.2022.04.006CrossRefPubMed

31.

Fridman H, Behar DM, Carmi S, Levy-Lahad E (2020) Preconception carrier screening yield: effect of variants of unknown significance in partners of carriers with clinically significant variants. Genet Med 22(3):646–653. https://doi.org/10.1038/s41436-019-0676-xCrossRefPubMed

32.

Liu P, Meng L, Normand EA et al (2019) Reanalysis of clinical exome sequencing data. N Engl J Med 380(25):2478–2480. https://doi.org/10.1056/NEJMc1812033CrossRefPubMedPubMedCentral

33.

Godino L, Turchetti D, Jackson L, Hennessy C, Skirton H (2016) Impact of presymptomatic genetic testing on young adults: a systematic review. Eur J Hum Genet 24(4):496–503. https://doi.org/10.1038/ejhg.2015.153CrossRefPubMed

34.

Veras DF, Ayres S, Boyle J, Mansour J, Newson AJ, on behalf of the Education, Ethics and Social Issues Committee of the Human Genetics Society of Australasia (2020) Human Genetics Society of Australasia position statement: Predictive and presymptomatic genetic testing in adults and children. Twin Res Hum Genet 23(3):184–189. https://doi.org/10.1017/thg.2020.51CrossRef

35.

Guttmacher AE, Porteous ME, McInerney JD (2007) Educating health-care professionals about genetics and genomics. Nat Rev Genet 8(2):151–157. https://doi.org/10.1038/nrg2007CrossRefPubMed

36.

Michaelson-Cohen R, Salzer-Sheelo L, Sukenik-Halevy R et al (2020) Teaching clinicians practical genomic medicine: 7 years’ experience in a tertiary care center. Genet Med 22(10):1703–1709. https://doi.org/10.1038/s41436-020-0868-4CrossRefPubMed

37.

Stoll K, Kubendran S, Cohen SA (2018) The past, present and future of service delivery in genetic counseling: keeping up in the era of precision medicine. Am J Med Genet C Semin Med Genet 178(1):24–37. https://doi.org/10.1002/ajmg.c.31602CrossRefPubMed

38.

Recchia G, Chiappi A, Chandratillake G, Raymond L, Freeman ALJ (2020) Creating genetic reports that are understood by nonspecialists: a case study. Genet Med 22(2):353–361. https://doi.org/10.1038/s41436-019-0649-0CrossRefPubMed

39.

Farmer GD, Gray H, Chandratillake G, Raymond FL, Freeman ALJ (2020) Recommendations for designing genetic test reports to be understood by patients and non-specialists. Eur J Hum Genet 28(7):885–895. https://doi.org/10.1038/s41431-020-0579-yCrossRefPubMedPubMedCentral

Titel: Ordering genetic testing by neurologists: points to consider
verfasst von: Avi Fellner
Yael Goldberg
Lina Basel-Salmon
Publikationsdatum: 08.05.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 8/2023
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-023-11758-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2023

Equating norms between the ALS Cognitive Behavioral Screen (ALS-CBS™) and the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) in non-demented ALS patients

Large diameter hemicraniectomy does not improve long-term outcome in malignant infarction

Diagnosing the benign paroxysmal positional vertigo via 1D and deep-learning composite model

Microvascular involvement in migraine: an optical coherence tomography angiography study

Path from discovery to recovery: therapeutic and diagnostic advances in Alzheimer's dementia